Cargando…

Optimal HIV testing strategies for South Africa: a model-based evaluation of population-level impact and cost-effectiveness

Although many African countries have achieved high levels of HIV diagnosis, funding constraints have necessitated greater focus on more efficient testing approaches. We compared the impact and cost-effectiveness of several potential new testing strategies in South Africa, and assessed the prospects...

Descripción completa

Detalles Bibliográficos
Autores principales:	Johnson, Leigh F., van Rensburg, Craig, Govathson, Caroline, Meyer-Rath, Gesine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6718403/ https://www.ncbi.nlm.nih.gov/pubmed/31477764 http://dx.doi.org/10.1038/s41598-019-49109-w

Ejemplares similares

The per-patient costs of HIV services in South Africa: Systematic review and application in the South African HIV Investment Case
por: Meyer-Rath, Gesine, et al.
Publicado: (2019)

The cost effectiveness and optimal configuration of HIV self-test distribution in South Africa: a model analysis
por: Jamieson, Lise, et al.
Publicado: (2021)

Designing an optimal HIV programme for South Africa: Does the optimal package change when diminishing returns are considered?
por: Chiu, Calvin, et al.
Publicado: (2017)

Revealed willingness-to-pay versus standard cost-effectiveness thresholds: Evidence from the South African HIV Investment Case
por: Meyer-Rath, Gesine, et al.
Publicado: (2017)

Prospects for HIV control in South Africa: a model-based analysis
por: Johnson, Leigh F., et al.
Publicado: (2016)

The cost and intermediary cost-effectiveness of oral HIV self-test kit distribution across 11 distribution models in South Africa
por: Matsimela, Katleho, et al.
Publicado: (2021)

The cost‐effectiveness of multi‐purpose HIV and pregnancy prevention technologies in South Africa
por: Quaife, Matthew, et al.
Publicado: (2018)

Inpatient Care Costs of COVID-19 in South Africa’s Public Healthcare System
por: Edoka, Ijeoma, et al.
Publicado: (2021)

Costs of integrating HIV self-testing in public health facilities in Malawi, South Africa, Zambia and Zimbabwe
por: Sande, Linda Alinafe, et al.
Publicado: (2021)

Secondary distribution of HIV self-test kits by HIV index and antenatal care clients: implementation and costing results from the STAR Initiative in South Africa
por: Zishiri, Vincent, et al.
Publicado: (2023)

The costs of interventions for type 2 diabetes mellitus, hypertension and cardiovascular disease in South Africa – a systematic literature review
por: Masuku, Sithabiso D., et al.
Publicado: (2022)

Reduction in initiations of HIV treatment in South Africa during the COVID pandemic
por: Benade, Mariet, et al.
Publicado: (2022)

The Impact of Company-Level ART Provision to a Mining Workforce in South Africa: A Cost–Benefit Analysis
por: Meyer-Rath, Gesine, et al.
Publicado: (2015)

Attrition through Multiple Stages of Pre-Treatment and ART HIV Care in South Africa
por: Fox, Matthew P., et al.
Publicado: (2014)

Cost-effectiveness of tenofovir gel in urban South Africa: model projections of HIV impact and threshold product prices
por: Terris-Prestholt, Fern, et al.
Publicado: (2014)

Markers of poor adherence among adults with HIV attending Themba Lethu HIV Clinic, Helen Joseph Hospital, Johannesburg, South Africa
por: Nnambalirwa, Maria, et al.
Publicado: (2016)

Role of data from cost and other economic analyses in healthcare decision-making for HIV, TB and sexual/reproductive health programmes in South Africa
por: Murphy, Joshua P, et al.
Publicado: (2021)

The Impact and Cost of Scaling up GeneXpert MTB/RIF in South Africa
por: Meyer-Rath, Gesine, et al.
Publicado: (2012)

A modelling framework for translating discrete choice experiment results into cost‐effectiveness estimates: an application to designing tailored and scalable HIV and contraceptive services for adolescents in Gauteng, South Africa
por: Govathson, Caroline, et al.
Publicado: (2023)

Cost-effectiveness of Remdesivir and Dexamethasone for COVID-19 Treatment in South Africa
por: Jo, Youngji, et al.
Publicado: (2021)

Modelling costs of community-based HIV self-testing programmes in Southern Africa at scale: an econometric cost function analysis across five countries
por: d'Elbée, Marc, et al.
Publicado: (2021)

Relative cost-effectiveness of long-acting injectable cabotegravir versus oral pre-exposure prophylaxis in South Africa based on the HPTN 083 and HPTN 084 trials: a modelled economic evaluation and threshold analysis
por: Jamieson, Lise, et al.
Publicado: (2022)

Adaptation of WHO’s generic tuberculosis patient cost instrument for a longitudinal study in Africa
por: Evans, Denise, et al.
Publicado: (2021)

Costs and cost-effectiveness of LEEP versus cryotherapy for treating cervical dysplasia among HIV-positive women in Johannesburg, South Africa
por: Lince-Deroche, Naomi, et al.
Publicado: (2018)

HIV Treatment as Prevention: Modelling the Cost of Antiretroviral Treatment—State of the Art and Future Directions
por: Meyer-Rath, Gesine, et al.
Publicado: (2012)

Scaling up Xpert MTB/RIF technology: the costs of laboratory- vs. clinic-based roll-out in South Africa
por: Schnippel, Kathryn, et al.
Publicado: (2012)

Correction: Costs and cost-effectiveness of LEEP versus cryotherapy for treating cervical dysplasia among HIV-positive women in Johannesburg, South Africa
por: Lince-Deroche, Naomi, et al.
Publicado: (2019)

Changing the South African national antiretroviral therapy guidelines: The role of cost modelling
por: Meyer-Rath, Gesine, et al.
Publicado: (2017)

Cost-Effectiveness of Cervical Cancer Screening in Women Living With HIV in South Africa: A Mathematical Modeling Study
por: Campos, Nicole G., et al.
Publicado: (2018)

Feasibility, Yield, and Cost of Active Tuberculosis Case Finding Linked to a Mobile HIV Service in Cape Town, South Africa: A Cross-sectional Study
por: Kranzer, Katharina, et al.
Publicado: (2012)

The cost of adding rapid screening for diabetes, hypertension, and COVID-19 to COVID-19 vaccination queues in Johannesburg, South Africa
por: Masuku, Sithabiso D., et al.
Publicado: (2023)

A quantitative assessment of the consistency of projections from five mathematical models of the HIV epidemic in South Africa: a model comparison study
por: Moolla, Haroon, et al.
Publicado: (2023)

Cost outcome analysis of decentralized care for drug-resistant tuberculosis in Johannesburg, South Africa
por: van Rensburg, Craig, et al.
Publicado: (2019)

Optimizing HIV testing services in sub‐Saharan Africa: cost and performance of verification testing with HIV self‐tests and tests for triage
por: Eaton, Jeffrey W, et al.
Publicado: (2019)

Effect of eliminating CD4-count thresholds on HIV treatment initiation in South Africa: An empirical modeling study
por: Bor, Jacob, et al.
Publicado: (2017)

Correction: The cost effectiveness and optimal configuration of HIV self-test distribution in South Africa: a model analysis
Publicado: (2023)

What will it take for an injectable ARV to change the face of the HIV epidemic in high‐prevalence countries? Considerations regarding drug costs and operations
por: Meyer‐Rath, Gesine, et al.
Publicado: (2023)

Oral HIV self-test kit distribution cost effective in South Africa?
Publicado: (2021)

Voices from the front lines: A qualitative study of integration of HIV, tuberculosis, and primary healthcare services in Johannesburg, South Africa
por: Lince-Deroche, Naomi, et al.
Publicado: (2020)

Treatment initiation among persons diagnosed with drug resistant tuberculosis in Johannesburg, South Africa
por: Evans, Denise, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_g4530g4tmp0n3kmsbp1igo1pg3